Management of Candida biofilms: state of knowledge and new options for prevention and eradication (Q38724208)

5 September 2017

1 reference

title

Management of Candida biofilms: state of knowledge and new options for prevention and eradication (English)

1 reference

5 September 2017

0 references

Helena Bujdáková

1

1 reference

5 September 2017

publication date

5 February 2016

1 reference

5 September 2017

number of pages

17

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

5 September 2017

volume

11

1 reference

5 September 2017

issue

2

1 reference

5 September 2017

page(s)

235-251

1 reference

Candida commensalism and virulence: the evolution of phenotypic plasticity

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The human commensal yeast, Candida albicans, has an ancient origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Importance of the Candida albicans cell wall during commensalism and infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida albicans pathogenicity mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida albicans SRR1, a putative two-component response regulator gene, is required for stress adaptation, morphogenesis, and virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Comparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Elevated chitin content reduces the susceptibility of Candida species to caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Efflux pump proteins in antifungal resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Stress response and expression of fluconazole resistance associated genes in the pathogenic yeast Candida glabrata deleted in the CgPDR16 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Clinical aspects of invasive candidiasis: endocarditis and other localized infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Characterization of post-hospital infections in adults requiring home parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Biofilm-based central line-associated bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Non-albicans Candida Infection: An Emerging Threat

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Treatment of fungal disease in the setting of neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

A prospective study of the patterns and dynamics of colonization with Candida spp. in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Insights into Candida tropicalis nosocomial infections and virulence factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

A review of Candida species causing blood stream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida infections of medical devices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

In-vivo Candida biofilms in scanning electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida albicans biofilm development, modeling a host-pathogen interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

A biochemical guide to yeast adhesins: glycoproteins for social and antisocial occasions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Participation of the Candida albicans surface antigen in adhesion, the first phase of biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Role of SFP1 in the Regulation of Candida albicans Biofilm Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Fungal biofilms, drug resistance, and recurrent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

How to build a biofilm: a fungal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida biofilms: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Clinical and therapeutic aspects of candidemia: a five year single centre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida biofilms and the host: models and new concepts for eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The effect of biomaterials and antifungals on biofilm formation by Candida species: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Anaerobic growth of Candida albicans does not support biofilm formation under similar conditions used for aerobic biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Proteomic analysis of the pH response in the fungal pathogen Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The impact of growth conditions on biofilm formation and the cell surface hydrophobicity in fluconazole susceptible and tolerant Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Influence of glucose concentration on the structure and quantity of biofilms formed by Candida parapsilosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Importance of Candida-bacterial polymicrobial biofilms in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Role of dimorphism in the development of Candida albicans biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida biofilms and their role in infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Genetics and genomics of Candida albicans biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Recent insights into Candida albicans biofilm resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Role for cell density in antifungal drug resistance in Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Hsp90 governs dispersion and drug resistance of fungal biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Quorum sensing and Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Quorum sensing in fungi--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Secretion of E,E-farnesol and biofilm formation in eight different Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Farnesol induces hydrogen peroxide resistance in Candida albicans yeast by inhibiting the Ras-cyclic AMP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Farnesol-induced apoptosis in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The metacaspase (Mca1p) has a dual role in farnesol-induced apoptosis in Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Two-component signal transduction proteins as potential drug targets in medically important fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Stress adaptation in a pathogenic fungus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida albicans biofilms produce antifungal-tolerant persister cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Resistance of Candida albicans biofilms to antifungal agents in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Patterns of Candida biofilm on intrauterine devices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Effects of fluconazole treatment of mice infected with fluconazole-susceptible and -resistant Candida tropicalis on fungal cell surface hydrophobicity, adhesion and biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Amphotericin B: an introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Effectiveness of the Photoactive Dye Methylene Blue versus Caspofungin on the Candida parapsilosis Biofilm in vitro and ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Fungal biofilms and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candidaemia in patients with an inserted medical device.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Role for the fibrinogen-binding proteins coagulase and Efb in the Staphylococcus aureus-Candida interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Fungal infectivities of implanted catheters due to Candida sp. Biofilms formation and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Incidence, risk factors, microbiology of venous catheter associated bloodstream infections--a prospective study from a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The antibiotic-lock technique for therapy of 'highly needed' infected catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Recent advances in natural product-based anti-biofilm approaches to control infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

In vitro and in vivo activity of a novel antifungal small molecule against Candida infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human β-defensin, and cytokine expression by engineered human oral mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

C. albicans growth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-W

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Polyelectrolyte multilayers fabricated from antifungal β-peptides: design of surfaces that exhibit antifungal activity against Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Antimicrobial and antibiofilm activity of designed and synthesized antimicrobial peptide, KABT-AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Tri

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

A silver ion-doped calcium phosphate-based ceramic nanopowder-coated prosthesis increased infection resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Antibiofilm properties of silver and gold incorporated PU, PCLm, PC and PMMA nanocomposites under two shear conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Synthesis of antibacterial TiO2/PLGA composite biofilms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Use of silver in the prevention and treatment of infections: silver review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida biofilm formation on voice prostheses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Metallic implant drug/device combinations for controlled drug release in orthopaedic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Silver nanoparticles in dental biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Broad spectrum antibacterial and antifungal polymeric paint materials: synthesis, structure-activity relationship, and membrane-active mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Anti-biofilm activity of low-molecular weight chitosan hydrogel against Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Photodynamic antimicrobial chemotherapy (PACT) for the treatment of malaria, leishmaniasis and trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Photosensitizers mediated photodynamic inactivation against virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Phenothiazinium derivatives for pathogen inactivation in blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Resistance in antimicrobial photodynamic inactivation of bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Immobilized photosensitizers for antimicrobial applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Diagnostic modalities for squamous cell carcinoma: an extensive review of literature-considering toluidine blue as a useful adjunct

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Treatment of oral fungal infections using antimicrobial photodynamic therapy: a systematic review of currently available evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Clay mineral particles as efficient carriers of methylene blue used for antimicrobial treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Photophysical and antibacterial properties of complex systems based on smectite, a cationic surfactant and methylene blue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Biofilms of Candida albicans serotypes A and B differ in their sensitivity to photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Photodynamic antimicrobial chemotherapy (PACT) inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

The use of Chitosan to enhance photodynamic inactivation against Candida albicans and its drug-resistant clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Gold Nanoparticle-Photosensitizer Conjugate Based Photodynamic Inactivation of Biofilm Producing Cells: Potential for Treatment of C. albicans Infection in BALB/c Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Candida albicansaspects of novel silane system-coated titanium and zirconia implant surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Peripherally inserted central catheter as a predominant risk factor for candidemia in critically ill patients in Internal Medicine wards in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.15.139

Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1093/JAC/DKR473

Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone

4 December 2022

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.IJANTIMICAG.2010.12.016

4 December 2022

Identifiers

DOI

10.2217/FMB.15.139

1 reference

5 September 2017

1 reference